“…[1][2][3][4][5][6][7][8] Isoindolo[2,1-a]quinazoline-5,11dione derivatives have been reported to exhibit various biological activities, including inhibition of tumor necrosis factor-α, which plays a major role in the treatment of rheumatoid arthritis, Crohn's disease, and ulcerative colitis. 9 Reported methods for the synthesis of isoindolo[2,1-a]quinazoline derivatives include reactions catalyzed by acetic acid, 10,11 montmorillonite K10, 9 β-cyclodextrin, 12 Saccharomyces cerevisiae, 13 CuO nanoparticles, 14 iodine in an ionic liquid, 15,16 17 or Fe in acetic acid. 18 Pyrrolo[1,2-a]quinoxalines have been prepared by a Mannich protocol, 19,20 a 1,3-dipolar cycloaddition reaction strategy, 21 a base-catalyzed approach, 22 visible light induced photoredox catalysis, 23 a modified Pictet-Spengler reaction catalyzed by TsOH with benzotriazole as an additive, 24 or intramolecular amidoalkylation-cyclization, 25 and by phasetransfer-catalyzed or trimethylsilyl cyanide catalyzed routes for the synthesis of their Reissert analogues.…”